Why Cough and Dysphagia Occur in Myasthenia Gravis
Cough and dysphagia in myasthenia gravis result from autoimmune-mediated weakness and fatigability of the striated muscles in the pharynx, larynx, and respiratory system, which are particularly vulnerable due to their high concentration of twitch fibers and fewer acetylcholine receptors.
Pathophysiologic Mechanism
The fundamental problem lies at the neuromuscular junction. Acetylcholine receptor antibodies block neurotransmission in striated muscles, and the twitch fibers in oropharyngeal and respiratory muscles are especially susceptible to this pathologic fatigability 1, 2. This creates a cascade of functional impairments:
Dysphagia Development
- Oropharyngeal swallowing requires rapid, highly coordinated neuromuscular actions from lip closure through upper esophageal sphincter opening 3
- When peripheral nerves and muscles controlling this complex sequence are affected, oropharyngeal dysphagia develops 3
- The weakness is characteristically variable and worsens with fatigue, distinguishing it from structural causes 1, 2
- In 15% of MG cases, dysphagia is the presenting symptom; as disease progresses, over 50% develop swallowing impairment, and in more than 50% of myasthenic crises, dysphagia precedes the crisis 3
Cough Impairment
Decreased cough strength results from weakness of respiratory and laryngeal muscles, leading to aspiration risk and increased likelihood of myasthenic crisis 4. The inability to generate adequate expiratory force compromises airway protection, creating a dangerous cycle where aspiration from dysphagia cannot be effectively cleared.
Clinical Significance and Mortality Risk
This combination is life-threatening. Dysphagia broadly affects respiratory safety due to increased aspiration risk, leading to insufficient nutrition, hydration, and most critically, aspiration pneumonia 3. The evidence shows:
- 75% of patients with silent aspiration develop aspiration pneumonia 5
- Dysphagia is associated with significantly higher mortality in MG patients 3
- Cough peak flow below 205 L/min identifies aspiration risk with 77% sensitivity and 90% specificity 4
Key Clinical Features
The pattern of symptoms reflects the underlying neuromuscular pathology:
- Bulbar involvement manifests as difficulty with chewing, swallowing, holding up the head, and slurred speech 1, 2
- Symptoms are fatigable and fluctuating, worsening throughout the day or with repetitive activity 1, 2
- Patients may show inability to swallow despite absence of drooling (a positive diagnostic sign indicating functional rather than structural obstruction) 6
- Respiratory muscle weakness compounds the problem, creating discoordination between swallowing and respiration 7
Diagnostic Implications
Before any surgical procedure, all patients suspected of having MG should have serum acetylcholine receptor antibody levels measured to avoid respiratory failure during surgery 8. Symptoms requiring immediate attention include drooping eyelids, double vision, drooling, difficulty climbing stairs, hoarseness, and dyspnea 8.
The esophageal involvement extends beyond the pharynx—esophageal transit is often compromised even in patients without dysphagia history, affecting striated muscles in the upper esophagus 9.
Critical Pitfall
Silent aspiration is extremely common and dangerous—patients may aspirate without coughing due to the combined weakness of both swallowing and cough mechanisms 5. This necessitates objective instrumental assessment (videofluoroscopy or fiberoptic endoscopic evaluation) rather than relying on patient-reported symptoms alone 5.